1 ad to life-threatening infections, including hepatic abscess.

2          Twelve of the 61 cases were primary hepatic abscesses.

3 atic abscesses, and 20 cases were persistent hepatic abscesses.

4 there were no deaths directly related to the hepatic abscesses.

5 w studies have reported the complications of hepatic abscesses.

6                                              Hepatic abscess, a rare complication after liver transpl

7  patients who had experienced 14 episodes of hepatic abscess, all in liver transplant recipients.

8  stenosis (16.6% versus 5.4%; P = 0.001) and hepatic abscess and biloma formation (16.7% versus 8.3%;

9      Twenty-nine of the cases were recurrent hepatic abscesses, and 20 cases were persistent hepatic

10 n and its possible mechanism of causation in hepatic abscess are discussed in this report, together w

11           Between 1980 and 2000, 61 cases of hepatic abscess in 22 patients with CGD were treated at

12 unodeficiency and should aggressively manage hepatic abscesses in these patients.

13                             The incidence of hepatic abscess is increased in patients undergoing stag

14                                              Hepatic abscesses occurring in patients with CGD represe

15 ent experienced uncontrolled biliary sepsis, hepatic abscess, or stent-related death.

16        The median age at the time of initial hepatic abscess presentation was 14 years.

17               Median time from transplant to hepatic abscess was 386 days (range 25-4,198).

18 isualization was normal and the diagnosis of hepatic abscess was made.

19                     Clinical presentation of hepatic abscess was similar to that described in non-imm

20 Klebsiella pneumoniae K1 is a major agent of hepatic abscess with metastatic disease in East Asia, wi